We've Been Wrong About Cancer For 100 Years - Dr. Thomas Seyfried, Boston College, DemystifySci #332

We've Been Wrong About Cancer For 100 Years - Dr. Thomas Seyfried, Boston College, DemystifySci #332

2 Stunden 2 Minuten

Beschreibung

vor 8 Monaten

Cancer is one of the most terrifying illnesses of our age - a
sudden change that happens silently inside our bodies and slowly
eats away at us until there’s nothing left. It’s also one of the
biggest failures of the pharmaceutical age - somewhere between 90
and 97% of all cancer drugs fail at clinical trials. Which is why
we’re unbelievably excited to bring you our conversation with Dr.
Thomas Seyfried, Professor of Biology at Boston College who
appears to be hot on the trail of a cure cancer that has nothing
to do with the oncology-industrial-complex. According to the
dozens of papers he and his colleagues have published over the
last few decades, a strict ketogenic diet coupled to a glutamine
inhibitor is sufficient to weaken cancer cells to the point that
the immune system can actually clear the tumor. A recent paper
from his group published in February of 2025 shows the stunning
effects of his protocol in a small group of eighteen glioblastoma
patients. Median survival for these patients for the last hundred
years has been 12-15 months, but with Seyfried’s intervention
appears to have been extended up to 84 months. That’s seven
years, for those keeping score.We sit down with Seyfried to take
apart his protocol, why it works for cancer, why no one’s heard
if it, and how everyone has completely misunderstood what cancer
actually is.MAKE HISTORY WITH US THIS
SUMMER:https://demystifysci.com/demysticon-2025PATREON
https://www.patreon.com/c/demystifysciPARADIGM
DRIFThttps://demystifysci.com/paradigm-drift-show(00:00)
Go!(00:07:33) - Reception of Metabolic Cancer Research(00:10:05)
- Breakthrough in Glioblastoma Treatment(00:14:49) -
Glutamine-Glutamate Cycle in Cancer(00:16:33) - Challenges and
Critiques of Standard Care(00:17:43) - Barriers to Implementing
Metabolic Therapies(00:24:19) - Radiation and Cancer
Treatment(00:26:07) - Metabolic Approach to Cancer(00:27:30) -
Evolutionary Biology's Role in Understanding Cancer(00:28:52) -
Mitochondria's Role in Cellular Destiny(00:31:39) - The Oxidative
Phosphorylation Process(00:35:28) - Cancer and Mitochondrial
Function(00:38:43) - Cellular Electrochemical Gradients(00:41:30)
- Cancer's Dependency on Fermentable Fuels(00:45:08) -
Glutamine's Role in Cancer Treatment(00:52:11) - Patient
Compliance and Dietary Challenges(00:55:33) - Glucose Ketone
Index for Health Monitoring(01:06:48) - Fenbendazole and Cancer
Research(01:10:02) - Medical Industry Business Models(01:13:27) -
Diets and Nutritional Ketosis(01:17:06) - Metabolic Variability
and Personalization(01:19:25) - Exercise and Metabolic
Health(01:23:43) - Historical Misconceptions in Cancer
Treatment(01:26:21) - Obesity and Cancer Prevention(01:28:00) -
Metabolic Theories of Cancer(01:47:18) - Metastatic Cancer
Origins(01:55:24) - Therapeutic and Collaborative
Approaches(01:59:57) - Practical Steps and
Transformations#CancerResearch, #glioblastoma, #CancerAwareness,
#Oncology, #CancerTreatment, #CancerSurvivor, #FightCancer,
#EndCancer, #CancerSupport, #ClinicalTrials, #CancerWarrior,
#BeatCancer, #CureCancer, #CancerFighter, #StayStrong,
#CancerCommunity, #philosophypodcast, #sciencepodcast,
#longformpodcast ABOUS US: Anastasia completed her PhD studying
bioelectricity at Columbia University. When not talking to
brilliant people or making movies, she spends her time painting,
reading, and guiding backcountry excursions. Shilo also did his
PhD at Columbia studying the elastic properties of molecular
water. When he's not in the film studio, he's exploring sound in
music. They are both freelance professors at various
universities. SOCIAL: - Discord: https://discord.gg/MJzKT8CQub-
Facebook: https://www.facebook.com/groups/DemystifySci-
Instagram: https://www.instagram.com/DemystifySci/- Twitter:
https://twitter.com/DemystifySciMUSIC: -Shilo Delay:
https://g.co/kgs/oty671

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15